Aspire BioPharma, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
2.560
-3.740 (-59.37%)
At close: Feb 21, 2025, 4:00 PM
2.600
+0.040 (1.56%)
After-hours: Feb 21, 2025, 7:57 PM EST
-59.37% (1D)
| Market Cap | 119.08M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 46.52M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,378,453 |
| Open | 4.950 |
| Previous Close | 6.300 |
| Day's Range | 2.500 - 4.950 |
| 52-Week Range | 2.500 - 14.070 |
| Beta | 0.05 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About ASBP
Aspire BioPharma, Inc. develops a disruptive technology through a soluble formulation which addresses emergencies, drug efficacy, dosage management, and response time. The company was incorporated in 2021 and is based in Humacao, Puerto Rico. [Read more]
Founded 2021
Country United States
Stock Exchange NASDAQ
Ticker Symbol ASBP
Website https://aspirebiolabs.com
News
Aspire Biopharma Holdings, Inc. Announces the Execution of Securities Purchase Agreement
NEW YORK CITY, NY / ACCESS Newswire / February 20, 2025 / Aspire Biopharma, Inc. ("Aspire" or the "Company"), a developer of a multi-faceted patent-protected disruptive drug delivery mechanism technol...
1 day ago - Accesswire